Evaluation of obstetric management of women with macrosomic foetuses in two Level 3 maternity hospitals in France and identification of predictive factors for obstetric and neonatal complications.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 22 09 2021
revised: 28 02 2022
accepted: 09 04 2022
pubmed: 16 5 2022
medline: 22 6 2022
entrez: 15 5 2022
Statut: ppublish

Résumé

Foetal macrosomia is associated with high maternal and neonatal morbidity; however, obstetric management of suspected macrosomia has not been well defined. This study aimed to analyse obstetric management in a population of women who delivered macrosomic new-borns and assess maternal and neonatal outcomes and risk factors for complications in such cases. This two-centre retrospective study conducted in France over a 10-year period comprised 1724 women who had delivered macrosomic new-borns (defined as those whose weight was > 90th percentile according to the Association of Users of Computerised Records in Perinatology, Obstetrics, and Gynaecology curve) from 37SA. In this study, the caesarean section and instrumental extraction rates were 24.1% and 15.7%, respectively, and the postpartum haemorrhage rate was 7%. The rate of shoulder dystocia was 23.1% (including brachial plexus injuries, 0.4%; and clavicular fractures, 2.0%). Significant risk factors for caesarean section were maternal height < 160 cm, nulliparity, history of caesarean section, excessive uterine height, induction of labour and duration of labour > 10 h. The risk factors for shoulder dystocia were maternal height < 160 cm and instrumental extraction. The study findings may help determine predictive factors for an unfavourable outcome at the time of delivery of a macrosomic foetus, thus allowing clinical teams to better anticipate and manage potential complications.

Identifiants

pubmed: 35569382
pii: S0301-2115(22)00296-2
doi: 10.1016/j.ejogrb.2022.04.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

34-39

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

R Larad (R)

CHU REIMS Maison Blanche, 45 Rue Cognacq Jay 51100 Reims, France. Electronic address: rlarad-riffault@chu-reims.fr.

U Ishaque (U)

CHU REIMS Maison Blanche, 45 Rue Cognacq Jay 51100 Reims, France.

D Korb (D)

CHU PARIS Robert Debré, 48 Boulevard Sérurier 75019 Paris, France; University de Paris, Centre for Epidemiology and Statistics Sorbonne Paris Cité, Obstetrical Perinatal and Pediatric Epidemiology Research Team, EPOPé, INSERM, INRA, France.

S Drame (S)

CHU REIMS Maison Blanche, 45 Rue Cognacq Jay 51100 Reims, France.

C Coutureau (C)

CHU REIMS Maison Blanche, 45 Rue Cognacq Jay 51100 Reims, France.

O Graesslin (O)

CHU REIMS Maison Blanche, 45 Rue Cognacq Jay 51100 Reims, France.

O Sibony (O)

CHU PARIS Robert Debré, 48 Boulevard Sérurier 75019 Paris, France.

R Gabriel (R)

CHU REIMS Maison Blanche, 45 Rue Cognacq Jay 51100 Reims, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH